v3.25.2
ACQUISITIONS, DIVESTITURES AND STRATEGIC INVESTMENTS - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended
Jan. 13, 2025
Apr. 01, 2024
Dec. 12, 2023
Jun. 28, 2025
Dec. 28, 2024
Jun. 29, 2024
Mar. 29, 2025
Business Acquisition [Line Items]              
Payments to acquire businesses, net of cash acquired       $ 0   $ 149,151  
Inventories, net       (360,527)     $ (365,141)
Property, plant and equipment, net       (286,865)     (284,052)
Prepaid expenses and other current assets       58,983     60,414
Other current liabilities       $ 145,643     148,133
Revision of Prior Period, Reclassification, Adjustment              
Business Acquisition [Line Items]              
Inventories, net         $ 26,400    
Property, plant and equipment, net         7,800    
Assets held for sale         $ 6,400    
Accrued liabilities             $ 100
Disposal Group, Held-for-Sale, Not Discontinued Operations | Whole Blood Business              
Business Acquisition [Line Items]              
Proceeds from divestiture $ 43,300            
Contingent consideration from divestiture $ 22,500            
Attune Medical              
Business Acquisition [Line Items]              
Upfront payment   $ 162,000          
Payments to acquire businesses, net of cash acquired   150,500          
Contingent consideration   25,300          
Business combination, estimated working capital adjustment   $ 400          
Attune Medical | Selling, general and administrative expenses              
Business Acquisition [Line Items]              
Legal and professional fees           $ 9,800  
OpSens, Inc.              
Business Acquisition [Line Items]              
Upfront payment     $ 254,500        
Payments to acquire businesses, net of cash acquired     10,600        
OpSens, Inc. | Selling, general and administrative expenses              
Business Acquisition [Line Items]              
Legal and professional fees     $ 6,600